The one thing that actually separates these providers is what you pay out of pocket on day one, before insurance, before coupons, before the fine print. That number determines whether most people even try.
Here’s what I found after going through pricing pages, pharmacy details, and program structures across nine telehealth options offering tirzepatide in 2025-2026.
1. HealthRX
Compounded tirzepatide starting at $149 a month is the lowest cash entry point I found among providers that actually name their pharmacy. HealthRX uses Manifest Pharmacy in Greer, South Carolina, a 503A compounding facility operating under USP-797 standards with lot-tracked batches from production to your door. That kind of traceability is uncommon at this price.
The intake is fully online. A U.S. board-certified physician reviews your assessment, typically within 24 hours, and the medication ships overnight at no extra charge. All 50 states. No hidden fees on the pricing page.
HealthRX also holds LegitScript certification (cert 50087439), which is an independently verified credential that most low-cost compounders skip.
The underlying trial data HealthRX references for tirzepatide comes from SURMOUNT-1, which showed roughly 21% average body weight reduction at 72 weeks in participants without diabetes. These are the trial numbers, not HealthRX’s own claims, and compounded versions are not FDA-approved products.
Verdict: Best overall value for cash-pay tirzepatide. Named pharmacy, overnight shipping, lowest price I found at this quality tier.
2. FormBlends
FormBlends operates a similar compounded GLP-1 model with physician oversight and an FDA-registered 503A pharmacy, but it goes further on transparency than most. It publishes per-product purity testing with actual numbers: HPLC purity percentages, mass spec identity results, endotoxin and sterility data. That’s rare. Most telehealth brands mention “quality testing” without showing you anything.
Tirzepatide runs around $349 per vial, semaglutide around $299. Noticeably higher than HealthRX. Delivery is available in 47 states rather than nationwide.
One genuine differentiator: FormBlends also carries peptides for recovery, cognitive support, and longevity under the same clinician model. If you want GLP-1s and other peptide protocols from one provider, this is the most organized option I found for that.
Verdict: Worth it if you want documented purity data or a broader peptide catalog. Not the cheapest, but arguably the most transparent on what’s in the vial.
3. Mochi Health
Compounded semaglutide at $99/month and tirzepatide at $199/month, with board-certified obesity-medicine clinicians doing the oversight. That clinical specialization matters. Monitoring here is more involved than bare-bones platforms.
Verdict: Good balance of price and medical structure. Tirzepatide is $50 more per month than HealthRX.
4. Henry Meds
Cash-pay compounded GLP-1s from roughly $179-249 in month one, with shipping typically arriving within 24-72 hours. Low monitoring overhead keeps costs down.
Verdict: Fast shipping, accessible pricing. Lighter clinical touch than Mochi.
5. MEDVi
Around $179 for the first month on compounded options, no contracts required. Clean intake process.
Verdict: Reasonable entry price. Less name recognition than others here, which isn’t a red flag on its own but is worth knowing.
6. Eden
Compounded semaglutide at approximately $149/month cash. Tirzepatide pricing isn’t always prominently listed. Established player in the compounded telehealth space.
Verdict: Solid for semaglutide. Less clear-cut for tirzepatide specifically.
7. Ro Body
Membership starts around $39 for the first month, then $74-149/month, with medications billed separately. Ro has a prior-authorization team for branded coverage, which is useful if you have insurance.
Verdict: Best structure if you’re pursuing insurance coverage. Cash-pay total cost adds up fast once meds are separate.
8. Hims & Hers
After the March 2026 settlement with Novo Nordisk, Hims & Hers moved away from compounded GLP-1s toward branded medications. Wegovy runs around $299/month through their platform, with insurance and savings cards potentially dropping it to near zero. Zepbound (branded tirzepatide) is listed around $399.
Verdict: Only makes financial sense with good insurance. Highest sticker price on this list.
9. PlushCare
Membership at $19.99/month, branded meds, same-day visits available. Insurance-forward model.
Verdict: Cheapest membership fee, but branded tirzepatide without insurance will cost you. Good if you have coverage.
Quick Price Comparison
| Provider | Compounded Tirz / Mo | Notes |
| HealthRX | ~$149 | All 50 states, overnight shipping |
| FormBlends | ~$349/vial | Published purity data, 47 states |
| Mochi Health | ~$199 | Obesity-medicine MDs |
| Henry Meds | ~$179-249 | Fast shipping |
| MEDVi | ~$179 | No contracts |
| Eden | See site | Sema focus |
| Ro Body | Meds separate | Insurance support |
| Hims & Hers | ~$399 branded | Post-settlement, branded only |
| PlushCare | Branded + insurance | Lowest membership fee |
One Thing to Keep in Mind
Compounded tirzepatide is not the same legal or regulatory category as FDA-approved Zepbound or Mounjaro. In early 2026, the FDA sent enforcement letters to over 30 telehealth and compounding businesses operating in this space. Picking a provider that names its pharmacy, holds independent certification, and shows you quality documentation is not optional caution, it’s basic homework. Prices shift and policies change, so confirm current availability directly before committing.
Common Questions
Does the $149/month price at HealthRX include the physician visit and shipping?
Yes, based on published pricing, the $149 figure covers the medication, overnight shipping, and physician review. There are no separate consultation fees listed. Always confirm this directly before checkout, since telehealth platforms do occasionally restructure their billing between the time an article is written and when you sign up.
Why does FormBlends cost so much more than HealthRX if both use 503A compounding pharmacies?
FormBlends publishes HPLC purity percentages, mass spec identity results, and sterility data for each product. That level of third-party testing costs money, and it’s reflected in the $349/vial price. You are partly paying for documentation, not just the drug. Whether that premium matters to you depends on how much weight you put on verifiable quality records.
After the Hims & Hers settlement with Novo Nordisk, can you still get compounded tirzepatide there?
No. Following the March 2026 settlement, Hims & Hers shifted to branded medications. Zepbound (branded tirzepatide) is listed around $399 through their platform. Compounded tirzepatide is no longer part of their model, which makes them a poor fit for anyone shopping purely on cash-pay price.
Is Mochi Health’s obesity-medicine oversight meaningfully different from what a general telehealth provider offers?
In practice, board-certified obesity-medicine physicians are trained specifically in metabolic treatment, dosing adjustments, and managing side effects in this patient population. General telehealth platforms often use primary care or urgent care clinicians. For most healthy adults, the difference may be minor, but if you have complicating factors, the specialization is worth considering.
Which providers on this list ship compounded tirzepatide to all 50 states?
HealthRX explicitly states all 50 states. FormBlends covers 47 states. The remaining providers vary, and several do not publish a clear state list on their pricing pages. State-level restrictions on compounded medications can change, so check directly with any provider before assuming your state is included.
Sources
- FDA: “Compounding and the FDA: Questions and Answers” (fda.gov)
- SURMOUNT-1 trial: Jastreboff et al., *New England Journal of Medicine*, 2022 (tirzepatide weight-loss outcomes in adults without diabetes)
- STEP 1 trial: Wilding et al., *New England Journal of Medicine*, 2021 (semaglutide weight management data)
- LegitScript certification registry (legitscript.com)
- FDA 503A compounding pharmacy framework (fda.gov)
- Novo Nordisk/Hims & Hers settlement reporting, Reuters, March 2026
